-

Xevant Enhances Automated Analytics Platform with AI to Revolutionize Healthcare Data Ingestion and Standardization

Xevant’s new AI-powered capabilities streamline data ingestion and pave the way for transformative improvements in pharmacy cost management for PBM stakeholders.

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in automated analytics for the pharmacy benefits industry, today announced the launch of new AI-powered capabilities designed to revolutionize the ingestion and standardization of healthcare data. These advancements address one of the most significant challenges faced by pharmacy benefit managers (PBMs), health plans, consultants, and employers—managing the influx of diverse, complex data formats quickly and efficiently.

Key Features:

  • Xevant’s new AI-powered platform automates the ingestion and analysis of data from multiple sources, eliminating manual processes and reducing time spent on data integration by as much as 65 percent.
  • The AI solution autonomously identifies and standardizes data from disparate formats into a consistent, usable structure, allowing PBM stakeholders to achieve real-time decision-making.
  • Through reinforcement learning, the system continuously improves by learning from human adjustments, ensuring greater accuracy and efficiency with every interaction.

“With the integration of AI, Xevant is addressing one of the most critical barriers to streamlined pharmacy benefit management,” said Brandon Newman, CEO of Xevant. “Our AI not only speeds up data ingestion and analysis, but it also empowers PBM stakeholders to make informed decisions faster and more efficiently than ever before.”

Pharmacy benefit management relies on vast amounts of data from multiple sources, all formatted differently. Traditionally, the process of standardizing this data for meaningful analysis has been time-intensive, slowing down decision-making. Xevant’s AI-driven approach tackles this issue head-on by autonomously transforming data from various formats into a consistent structure at scale. This innovation provides PBM stakeholders with immediate, actionable insights, enabling them to make faster, data-driven decisions that directly affect cost management and patient care quality.

The platform’s AI capabilities with reinforcement learning, position Xevant as a forward-thinking leader in healthcare data analytics. By reducing the manual burden on PBM stakeholders and streamlining complex data processes, Xevant’s solution not only improves pharmacy benefit management but also enhances patient outcomes by allowing quicker, more accurate decision-making.

Xevant’s continued investment in AI will further extend these capabilities, helping more clients achieve the lowest net costs faster while optimizing pharmacy benefits and improving affordability. These improvements pave the way for a significant shift in managing data across the healthcare industry.

About Xevant

Xevant is an industry leader in pharmacy benefits analytics and automation. By combining advanced data integration technologies and real-time insights, Xevant enables pharmacy benefit managers (PBMs), health plans, and consultants to deliver cost savings, optimize pharmacy benefit programs, and improve patient care.

Contacts

Media Contact:
Cassaundra Kalba
xevant@society22pr.com

Xevant


Release Versions

Contacts

Media Contact:
Cassaundra Kalba
xevant@society22pr.com

More News From Xevant

Xevant Expands Ivim at Work and Introduces New Lower Pricing on Wegovy® and Ozempic® for Employers Nationwide

LEHI, Utah--(BUSINESS WIRE)--Xevant today announced expanded access to new, lower pricing for its employer-focused medical weight-loss program, Ivim at Work, significantly reducing the cost of GLP-1 therapy for self-funded employers, brokers, and PBMs. The enhanced pricing structure is fully optimized through Xevant’s VerX platform, which identifies and delivers the lowest-cost, clinically appropriate options across the pharmacy ecosystem. The update introduces pricing starting at $199 per mont...

Xevant Expands VerX Platform, Delivering AI-Driven Pharmacy Cost Optimization in the Emerging RxTech Era

LEHI, Utah--(BUSINESS WIRE)--Xevant today announced major advances to its VerX™ Platform, unveiling a new set of interconnected systems — Cortex, Pulse, Axis, and Nudge — that together demonstrate the operational reality of RxTech, the emerging technology segment transforming pharmacy benefits to eliminate more than $250 billion in prescription waste and deliver the lowest net cost for medications. Following VerX’s initial debut earlier this summer, Xevant now shows how its AI-driven platform d...

Xevant White Paper Highlights Opportunities for Transparency in PBM Model, Introduces VerX as Breakthrough for Cost Optimization

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in pharmacy benefits analytics, today announced the release of a new white paper: “Cracking Open the PBM Black Box: Unlocking Transparency and Partnership with VerX.” The report explores the challenges faced by traditional pharmacy benefit manager (PBM) models and highlights how VerX is helping plan sponsors and PBMs align around data-driven insights to improve cost management and Performance. Evolving Challenges in the PBM Model The white paper not...
Back to Newsroom